Hard Evidence for Second-Line Chemo in Gastric CancerHard Evidence for Second-Line Chemo in Gastric Cancer
Dr. David Kerr reports on a Korean meta-analysis that clearly supports use of second-line chemotherapy in locally advanced or metastatic gastric cancer at the time of relapse. Medscape Oncology
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Hematology-Oncology Commentary Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Gastric (Stomach) Cancer | Gastroenterology | Hematology